Aperçu rapide pour Mitogen-Activated Protein Kinase 14 (MAPK14) Peptide (ABIN979797)
Antigène
MAPK14
(Mitogen-Activated Protein Kinase 14 (MAPK14))
Origine
Humain
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
Attributs du produit
This is a synthetic peptide designed for use in combination with anti-MAPK14 antibody (Catalog #: AVARP06004_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
MAPK14
Reactivité: Humain, Souris, Rat, Chien, Poisson zèbre (Danio rerio)
Hôte: Synthetic
BP
Indications d'application
Each Investigator should determine their own optimal working dilution for specific applications.
Restrictions
For Research Use only
Format
Lyophilized
Reconstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Concentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Conseil sur la manipulation
Avoid repeated freeze-thaw cycles.
Stock
-20 °C
Stockage commentaire
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Antigène
MAPK14
(Mitogen-Activated Protein Kinase 14 (MAPK14))
Sujet
MAPK14 is a member of the MAP kinase family. MAP kinases act as an integration point for multiple biochemical signals, and are involved in a wide variety of cellular processes such as proliferation, differentiation, transcription regulation and development. This kinase is activated by various environmental stresses and proinflammatory cytokines. The activation requires its phosphorylation by MAP kinase kinases (MKKs), or its autophosphorylation triggered by the interaction of MAP3K7IP1/TAB1 protein with this kinase. The substrates of this kinase include transcription regulator ATF2, MEF2C, and MAX, cell cycle regulator CDC25B, and tumor suppressor p53, which suggest the roles of this kinase in stress related transcription and cell cycle regulation, as well as in genotoxic stress response. Four alternatively spliced transcript variants of this gene encoding distinct isoforms have been reported.
Protein Interaction Partner: CDC25B,NCF1C,ATF2,BCL2,CDC25B,CDC25C,CDX2,CREB1,CSNK2A2,CSNK2B,DDIT3,DUSP1,DUSP10,DUSP16,DUSP2,DUSP22,DUSP4,DUSP7,DUSP9,DYRK1B,EEA1,EEF2K,EIF4EBP1,ELK1,ELK3,ESR1,FAM48A,FKBP8,FLNA,GADD45A,GMFB,GRB2,HNF4A,HSF4,HTRA2,IRAK1,JDP2,JUNB,KRT18,KRT8,MAFA,MAP2K1,MAP2K3,MAP2K4,MAP2K6,MAP3K7,MAPK1,MAPK3,MAPK8,MAPKAPK2,MAPKAPK3,MAPKAPK5,MAX,MBP,MEF2A,MEF2C,MITF,MKNK1,MKNK2,NCF1,NCOA3,NFATC1,NFATC4,NUP153,PLA2G4A,PML,PPARGC1A,PTPN7,RET,RPS6KA4,SCN8A,SHC1,SLC9A1,SMAD3,SMAD7,SPAG9,STAT1,STAT4,STK39,TAB1,TRAF6,ZFP36L1,ZFYVE20,ZNHIT1,AKT1,ATF2,ATF2,ATF2,ATF2,CDC25A,CDC25B,CDC25C,CSNK2A1,DDIT3,DUSP1,DUSP10,DUSP10,DUSP16,DUSP4,DUSP6,DYRK1B,EGFR,ELK1,ELK1,ELK4,ELK4,ETV1,FUBP1,GMFB,HTRA2,JUN,KARS,KRT8,MAP2K3,MAP2K3,MAP2K6,MAP2K7,MAPK1,MAPK14,MAPK3,MAPKAPK2,MAPKAPK3,MEF2A,MKNK1,MKNK1,PLCB2,RPS6KA3,RPS6KA4,RPS6KA5,Rps6kb1,SLC12A2,SMAD7,SPAG9,STK39,TAB1,TAB1,TGFBR1,ZFP36L1